LBF20306PG01: Difference between revisions
No edit summary |
No edit summary |
(No difference)
| |
Revision as of 09:03, 20 December 2008
| IDs and Links | |
|---|---|
| LipidBank | XPR1733 |
| LipidMaps | LMFA03010051 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20306PG01 |
| 15-deoxy-Δ12.14-Prostaglandin D2 | |
|---|---|
| |
| Structural Information | |
| 9α-hydroxy-11-oxo-prosta-5Z,12E,14E-trien-1-oic acid | |
| |
| Formula | C20H30O4 |
| Exact Mass | 334.21440944799997 |
| Average Mass | 334.4498 |
| SMILES | C([C@H]1CC=CCCCC(O)=O)(C(C[C@@H]1O)=O)=CC=CCCCCC |
| Physicochemical Information | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | lmax=296nm e296=18300 |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | PGD2 and other metabolites are separated with HPLC. Please reffer following paper. SoderstromMet al. |
| Reported Metabolites, References | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
